https://www.businesswire.com/news/home/20200110005514/en/

MENLO PARK, Calif.--(BUSINESS WIRE)--Jan 10, 2020--

Alydia Health, a clinical-stage medical device company developing an innovative technology to prevent maternal morbidity and mortality caused by abnormal postpartum bleeding and hemorrhage, today announced that Erica Rogers has been appointed to the company's board of directors as a strategic advisor.